Bandingkan Harga & Kinerja Multi Indocitra Tbk. (MICE) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Multi Indocitra Tbk. dan Tempo Scan Pacific Tbk.: Multi Indocitra Tbk. diperdagangkan di Rp530 (kapitalisasi pasar 303 M, volume 24 jam 154,1 rb), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.590 (kapitalisasi pasar 11,36 T, volume 24 jam 1,77 jt). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 37,5× kapitalisasi pasar Multi Indocitra Tbk., dan Tempo Scan Pacific Tbk. lebih aktif diperdagangkan (1,77 jt vs 154,1 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MICE | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 303 M | 11,36 T |
Volume | 154,1 rb | 1,77 jt |
Lot | 1,54 rb | 17,71 rb |
Perputaran | 81,24 jt | 4,61 M |
Harga Rata-rata | 527,17 | 2.603,9 |
Nilai Transaksi | 81,24 jt | 4,61 M |
Harga Ekuilibrium Indikatif | — | 2.590 |
Volume Ekuilibrium Indikatif | — | 300 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Multi Indocitra Tbk.
PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.
Selengkapnya di halaman MICE →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
